Similar to the CAD findings, men with MS showed significantly higher serum LCN2 levels than their non-MS counterparts (40.2 (31.9-59.4) vs. 32.0 (21.7-47.6) ng/mL, p < 0.01, Figure 2A). Here, LCN2 is linked to coronary artery disorder.